Uenaka N, Sato E, Horimoto Y, Kawai S, et al. CD8-Positive T-Cells Are Key Immune Cells for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer. Anticancer Res 2024;44:4525-4536.
PMID: 39348963